Mechanism of action of the sesquiterpene compound helenalin in rhabdomyosarcoma cells
Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in paediatric patients. Relapsed or refractory RMS shows very low 5-year survival rates, which urgently necessitates new chemotherapy agents. Herein, the sesquiterpene lactone, helenalin, was investigated as a new potential therapeutic...
Автори: | Mun, H, Townley, HE |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
MDPI
2021
|
Схожі ресурси
Схожі ресурси
-
Mechanism of Action of the Sesquiterpene Compound Helenalin in Rhabdomyosarcoma Cells
за авторством: Hakmin Mun, та інші
Опубліковано: (2021-12-01) -
CD44 and CD221 directed magnetic cubosomes for the targeted delivery of helenalin to rhabdomyosarcoma cells
за авторством: Mun, H, та інші
Опубліковано: (2022) -
Active targeting of rhabdomyosarcoma cells using helenalin-loaded functionalised cubosomes
за авторством: Mun, HM
Опубліковано: (2023) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
за авторством: Feng, XiaoLing, та інші
Опубліковано: (2013) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
за авторством: Lim Chuan, та інші
Опубліковано: (2012-07-01)